Related Experiment Video
Updated: Mar 26, 2026
05:19
A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
Published on: November 7, 2025
1.0K
[Active surveillance for early prostate cancer: current status and problems]
Nihon Rinsho. Japanese Journal of Clinical Medicine
|January 23, 2016
Summary
Active surveillance (AS) is a key strategy for managing early-stage prostate cancer (PC) to avoid overtreatment. However, AS is underutilized in Japan due to clinical practice challenges.
Area of Science:
- Urology
- Oncology
Context:
- Widespread prostate-specific antigen (PSA) testing has increased early-stage, favorable-risk prostate cancer (PC) diagnoses.
- Concerns regarding overdiagnosis and overtreatment of PC have emerged.
- Radical treatment is not optimal for all PC patients, particularly those with favorable risk profiles.
Purpose:
- To address the underutilization of active surveillance (AS) for favorable-risk PC in Japan.
- To identify and elucidate the challenges hindering AS implementation in clinical practice.
- To propose solutions for improving AS adoption in Japan.
Summary:
- Active surveillance (AS) is presented as the primary strategy to mitigate overtreatment in favorable-risk prostate cancer (PC).
- Despite its benefits, AS is significantly underused in Japan compared to international standards.
- Barriers to AS implementation in Japanese clinical settings are explored, with a focus on proposing actionable solutions.
Impact:
- Promoting AS can reduce overtreatment and associated patient morbidity.
- Addressing implementation challenges can increase AS adoption rates in Japan.
- Improved AS strategies may lead to better patient outcomes and resource allocation in PC management.
